Resources

Sughrue’s ANDA Roadshow Opens in Taiwan March 31, 2015

3/31/2015
The focus of this year’s conference will be “Most Recent Trend of U.S. Bio Pharmaceutical Legal Developments for Taiwanese Companies”

Join Sughrue’s ANDA team as they participate in a conference on Trends in the Bio Pharmaceutical Patent field. The conference will cover current topics in the ANDA industry including:

Opening remarks by Susan Pan

Early Stage Navigation of the Patent Landscape and Paragraph IV Challenge under 505(b)(2) and 505(j) – Chid Iyer and Azy Kokabi

Early Stage Resolution of a 505(b)(2) or 505(j) case – Chid Iyer

Effective Litigating a 505(b)(2) of 505(j) case and a Typical Timeline for a litigation under Paragraph IV – Mark Boland and Susan Pan

Case law update impacting Paragraph IV cases in the past year in the Federal Circuit and notable District Court Decisions – Sunhee Lee & Azy Kokabi

Litigating alleged infringement of various types of claims usually found in Paragraph IV litigations – Mark Boland

Effective and Economic launching strategies in view of forfeiture provisions – Sunhee Lee

IP and Litigation Strategies of Biosimilar/Biologics Development in the United States – Azy Kokabi